| 2005 |
C7orf11/TTDN1 (MPLKIP) localizes to the nucleus, as determined by comparative immunofluorescence analysis, and does not influence TFIIH directly. |
Immunofluorescence / comparative immunofluorescence analysis |
American journal of human genetics |
Medium |
15645389
|
| 2007 |
TTDN1 (MPLKIP) physically interacts with Plk1 (polo-like kinase 1); this interaction requires phosphorylation of Thr120 in a consensus Plk1-binding motif at TTDN1's C terminus, as site-directed mutagenesis of Thr120 abolishes the interaction. |
Yeast two-hybrid screen, site-directed mutagenesis, co-localization |
Cellular and molecular life sciences : CMLS |
Medium |
17310276
|
| 2007 |
TTDN1 (MPLKIP) is phosphorylated by Cdk1 during mitosis at multiple residues including Ser93 and Ser104; this phosphorylation is required for its interaction with Plk1. |
Site-directed mutagenesis, in-cell phosphorylation assays |
Cellular and molecular life sciences : CMLS |
Medium |
17310276
|
| 2007 |
TTDN1 (MPLKIP) co-localizes with Plk1 at the centrosome in mitosis and at the midbody during cytokinesis; overexpression or siRNA knockdown of TTDN1 causes multi-polar spindles and multiple nuclei, indicating a role in regulating mitosis and cytokinesis. |
Immunofluorescence co-localization, siRNA knockdown, overexpression |
Cellular and molecular life sciences : CMLS |
Medium |
17310276
|
| 2007 |
Mutations in C7orf11/TTDN1 (MPLKIP) do not affect the cellular response to UV light or the steady-state level of TFIIH, indicating that MPLKIP's disease mechanism is distinct from the TFIIH-dependent photosensitive TTD pathway. |
UV survival assay, western blot for TFIIH levels in patient cells |
Human mutation |
Medium |
16977596
|
| 2016 |
A splice variant (c.339+1G>A) in MPLKIP causes intron retention, leading to protein truncation and loss of a phosphorylation site, functionally validating the importance of the phosphorylation site for full-length protein. |
Splicing assay, Sanger sequencing, exome sequencing |
BMC medical genetics |
Low |
26880286
|
| 2023 |
MPLKIP directly binds to the RNA lariat debranching enzyme DBR1, as demonstrated by mass spectrometry-based interaction proteomics; MPLKIP-deficient primary fibroblasts have reduced steady-state DBR1 protein levels, indicating that MPLKIP stabilizes DBR1. |
Mass spectrometry-based interaction proteomics (AP-MS), western blot in MPLKIP-deficient fibroblasts |
EMBO molecular medicine |
High |
37800682
|
| 2023 |
MPLKIP interacts with core splicing factors; in MPLKIP-deficient cells, impaired splicing is observed in human skin equivalents, leading to an imbalanced proteome affecting keratinocyte differentiation and skin development. |
Mass spectrometry-based interaction proteomics, human skin equivalents (HSE) model, proteomics |
EMBO molecular medicine |
Medium |
37800682
|
| 2023 |
MPLKIP (trichothiodystrophy nonphotosensitive 1) directly binds human Dbr1 and stimulates its catalytic efficiency 19-fold in vitro; this activation is mediated through Dbr1's intrinsically disordered C-terminal domain, which MPLKIP requires for activation, as Dbr1 from Entamoeba histolytica (lacking this domain) is unaffected. |
In vitro debranching assay with purified proteins, NMR (disordered domain characterization), sequence analysis |
The Journal of biological chemistry |
High |
37507019
|